Interested in submitting an e–Pearl? Click here!
Brought to you by the Resident and Fellow Section of Neurology®.
May 29, 2012
Hashimoto Encephalopathy is a highly variable clinical syndrome defined by the triad of encephalopathy, elevated antithyroid antibody levels, and clinical improvement after treatment with high dose corticosteroids. Several serum thyroid antibodies may be positive, including thyroperoxidase antibody, thyroglobulin antibody, and thyroid microsomal antibody, but they are not necessarily directly pathogenic. In the appropriate clinical context, the presence of these antibodies may be diagnostic, but approximately 10% of the general population may have elevated serum anti–thyroperoxidase antibodies. Antibody type and levels do not correlate with the severity of symptoms and may not correlate with degree of recovery after treatment.
1. Afshari M, Afshari ZS, Schuele SU. Pearls & Oy–sters: Hashimoto Encephalopathy. Neurology 2012; 78: e134–e137.
2. Castillo P, Woodruff B, Caselli R, et al. Steroid–responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 2006;63:197–202.
Submitted by: Jennifer E. Fugate, DO
Disclosure: Dr. Fugate serves on the editorial team for the Neurology Resident and Fellow Section.
For more clinical pearls and other articles of interest to neurology trainees, visit www.neurology.org and click on the link to the Resident and Fellow Pages. Click here to visit the E–Pearl of the Week Archive.
Click here to listen to this week's Neurology® Podcast.